Outcome of patients treated by a novel thin-strut cobalt-chromium stent in the drug-eluting stent era: Results of the SKICE (skylor in real world practice) registry

Catheterization and Cardiovascular Interventions

Volumn 73, Issue 4, 2009, Pages 457-465

  Burzotta, Francesco ^a   Trani, Carlo ^a   Todaro, Daniel ^a   Mazzari, Mario Attilio ^a   Porto, Italo ^a   De Vita, Maria ^a   Brugaletta, Salvatore ^a   Coroleu, Santiago Federico ^a   Niccoli, Giampaolo ^a   Leone, Antonio Maria ^a   Giammarinaro, Maura ^a   Mongiardo, Rocco ^a   Schiavoni, Giovanni ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Outcome; Percutaneous coronary intervention; Stent

Indexed keywords

ANTITHROMBOCYTIC AGENT; CHROMIUM; CLOPIDOGREL; COBALT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; RISK ASSESSMENT; SAPHENOUS VEIN GRAFT; SCORING SYSTEM; ST SEGMENT ELEVATION; STENT THROMBOSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR DISEASES; CHROMIUM ALLOYS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; ITALY; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT SELECTION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 65549158101     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21882     Document Type: Article

References (21)

1. Sianos G, Papafaklis MI, Daemen J, Vaina S, van Mieghem CA, van Domburg RT, Michalis LK, Serruys PW. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: The importance of thrombus burden. J Am Coll Cardiol 2007;50:573-583.
2. Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Van den Branden F, Van Langenhove G; DELAYED RRISC (Death and Events at Long-term follow-up Analysis: Extended Duration of the Reduction of Restenosis In Saphenous vein grafts with Cypher stent) Investigators. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: Results from the randomized DELAYED RRISC Trial. J Am Coll Cardiol 2007;50:261-267.
3. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130.
4. Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: Results from the PREMIER registry. Circulation 2006;113:2803-2809.
5. Airoldi F, Colombo A, Morici N, Latib A, Cosgrave J, Buellesfeld L, Bonizzoni E, Carlino M, Gerckens U, Godino C, Melzi G, Michev I, Montorfano M, Sangiorgi GM, Qasim A, Chieffo A, Briguori C, Grube E. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation 2007;116:745-754.
6. Kaiser C, Brunner-La Rocca HP, Buser PT, Bonetti PO, Osswald S, Linka A, Bernheim A, Zutter A, Zellweger M, Grize L, Pfisterer ME; BASKET Investigators. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: Randomised Basel stent Kosten Effektivitaüts trial (BASKET). Lancet 2005;366:921-929.
7. Praz L, Cook S, Meier B. On behalf of the working group on interventional cardiology (WG 10) of the European society of cardiology/ European association of percutaneous cardiovascular interventions (EAPCI). Eurointerv 2007;3:442-446.
8. Pache J, Kastrati A, Mehilli J, Schuühlen H, Dotzer F, Hausleiter J, Fleckenstein M, Neumann FJ, Sattelberger U, Schmitt C, Muüller M, Dirschinger J, Schoümig A. Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol 2003;41: 1283-1288.
9. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9-13.
10. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL Jr. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American college of cardiology/american heart association task force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee on percutaneous transluminal coronary angioplasty). Circulation 1988;78:486-502.
11. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation 1999;100:1872-1878.
12. Serruys PW, Kay IP, Disco C, Deshpande NV, de Feyter PJ. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: Results of a meta-analysis of the Belgian Netherlands Stent study (BENESTENT) I. BENESTENT II Pilot, BENESTENT II and MUSIC trials. Multicenter ultrasound stent in coronaries. J Am Coll Cardiol 1999;34:1067-1074.
13. Romagnoli E, Burzotta F, Trani C, Siviglia M, Biondi-Zoccai GG, Niccoli G, Leone AM, Porto I, Mazzari MA, Mongiardo R, Rebuzzi AG, Schiavoni G, Crea F. Euroscore as predictor of inhospital mortality after percutaneous coronary intervention. Heart. 2008 (Epub ahead of print).
14. Pache J, Dibra A, Mehilli J, Dirschinger J, Schömig A, Kastrati A. Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: A prospective, randomized trial. Eur Heart J 2005;26:1262-1268.
15. Xu YW, Wei YD, Tang K, Chen YQ, Li WM, Yu XJ, Qin YW, Qi GX, Qu P, Hou YQ, Jain A, Grant P, Ramesh G, Ramesh B, Piamsomboon C, Kuanprasert S, Gwon HC, Cho YH, Kamar HH, Huang CX. Multi-link vision and minivision stent registry in Asian patients with coronary artery disease: A prospective, multi-center study. Chin Med J (Engl) 2007;120:1093-1096.
16. Kereiakes DJ, Cox DA, Hermiller JB, Midei MG, Bachinsky WB, Nukta ED, Leon MB, Fink S, Marin L, Lansky AJ; Guidant Multi-Link Vision Stent Registry Investigators. Usefulness of a cobalt chromium coronary stent alloy. Am J Cardiol 2003; 92:463-466.
17. Strehblow C, Gyoüngyoüsi M, Zenker G, Wallner H, Heigert M, Siostrzonek P, Tischler R, Probst P, Lang I, Sochor H, Glogar D. Small vessel stenting with cobalt-chromium stents (Arthos Pico) in a real world setting. Coron Artery Dis 2007;18:305-311.
18. Legrand V, Kelbaek H, Hauptmann KE, Glogar D, Rutsch W, Grollier G, Vermeersch P, Elias J, De Cock CC; CLASS Investigators. Clinical and angiographic analysis with a cobalt alloy coronary stent (driver) in stable and unstable angina pectoris. Am J Cardiol 2006;97:349-352.
19. Blanchard D, Garcia E, Nagai H, Paunovic D, Suttorp M, Kornowski R, Danzi G, Urban P, Moseri M, Juergens C, Guyon P, Nowak B, Tresukosol D, Farshid A, Yeend R, on behalf of MATSURI investigators. A novel ultra-thin bare metal stent (BMS): Results from a worldwide registry. EuroInterv 2007;3: 249-255.
20. Sketch MH Jr, Ball M, Rutherford B, Popma JJ, Russell C, Kereiakes DJ; Driver investigators. Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system. Am J Cardiol 2005;95:8-12.
21. Koolen JJ, De Vita M. LEONARDO: Clinical evaluation of a last generation coronary stent in a real world typical non-DES population. A prospective, single-centre registry. Interv Cardiol 2007;38-40.